An existing malaria drug could improve the effectiveness of a new class of cancer therapies, called glutaminase inhibitors, if used in combination, researchers at Weill Cornell Medicine-Qatar (WCM-Q) discovered in a new study.
Back to News
Weill Cornell MedicineOffice of External Affairs 1300 York AvenueBox 314 New York, NY 10065 Phone: (646) 962-9476
